Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Revista da Sociedade Brasileira de Medicina Tropical |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000200249 |
Resumo: | Abstract Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months. |
id |
SBMT-1_f6308e7919a1107aecf783d4daaa2f63 |
---|---|
oai_identifier_str |
oai:scielo:S0037-86822018000200249 |
network_acronym_str |
SBMT-1 |
network_name_str |
Revista da Sociedade Brasileira de Medicina Tropical |
repository_id_str |
|
spelling |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapyParacoccidioidomycosisInfliximabImmunosuppressionAbstract Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months.Sociedade Brasileira de Medicina Tropical - SBMT2018-04-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000200249Revista da Sociedade Brasileira de Medicina Tropical v.51 n.2 2018reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0222-2017info:eu-repo/semantics/openAccessCovre,Lúcia Carla PolacoHombre,Pâmela MazziniFalqueto,AloísioPeçanha,Paulo MendesValim,Valériaeng2018-05-11T00:00:00Zoai:scielo:S0037-86822018000200249Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2018-05-11T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false |
dc.title.none.fl_str_mv |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
title |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
spellingShingle |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy Covre,Lúcia Carla Polaco Paracoccidioidomycosis Infliximab Immunosuppression |
title_short |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
title_full |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
title_fullStr |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
title_full_unstemmed |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
title_sort |
Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy |
author |
Covre,Lúcia Carla Polaco |
author_facet |
Covre,Lúcia Carla Polaco Hombre,Pâmela Mazzini Falqueto,Aloísio Peçanha,Paulo Mendes Valim,Valéria |
author_role |
author |
author2 |
Hombre,Pâmela Mazzini Falqueto,Aloísio Peçanha,Paulo Mendes Valim,Valéria |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Covre,Lúcia Carla Polaco Hombre,Pâmela Mazzini Falqueto,Aloísio Peçanha,Paulo Mendes Valim,Valéria |
dc.subject.por.fl_str_mv |
Paracoccidioidomycosis Infliximab Immunosuppression |
topic |
Paracoccidioidomycosis Infliximab Immunosuppression |
description |
Abstract Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000200249 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000200249 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0037-8682-0222-2017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
dc.source.none.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical v.51 n.2 2018 reponame:Revista da Sociedade Brasileira de Medicina Tropical instname:Sociedade Brasileira de Medicina Tropical (SBMT) instacron:SBMT |
instname_str |
Sociedade Brasileira de Medicina Tropical (SBMT) |
instacron_str |
SBMT |
institution |
SBMT |
reponame_str |
Revista da Sociedade Brasileira de Medicina Tropical |
collection |
Revista da Sociedade Brasileira de Medicina Tropical |
repository.name.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT) |
repository.mail.fl_str_mv |
||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br |
_version_ |
1752122161131159552 |